Top Markets
Coin of the day
Solventum Corporation Solventum Corporation

Solventum Corporation

SOLV
Clasificación en acciones #1472
Solventum Corporation, established in 2023 and headquartered in Saint Paul,... Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
Precio por acción
$91.14
Última sincronización: 2026-08-24
Capitalización bursátil
$15.78B
Cambio (1 día)
1.73%
Cambio (1 año)
25.28%
País
US
Comercio Solventum Corporation (SOLV)

Categoría

EPS de Solventum Corporation (SOLV)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Solventum Corporation, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Solventum Corporation desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras